Patents-Review.com
ClassID:

95327 ⎘

C07D453/00 - CPC Classification

Classification description:

Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids

Sub-classes:
Recent Application in this class:
#1
20230285378
2023-09-14

Anti-Viral Compounds

 #2
20210261557
2021-08-26

GLUCOSYLCERAMIDE SYNTHASE INHIBITORS

 #3
20210078990
2021-03-18

TYROSINE KINASE INHIBITORS

 #4
20200385377
2020-12-10

Hepatitis B antiviral agents

 #5
20200181136
2020-06-11

Prodrugs of quinuclidine ring-containing muscarinic agonists and compositions and methods thereof

 #6
20200147593
2020-05-14

Cinchonium betaine catalysts and methods of using same

 #7
20200048266
2020-02-13

GLUCOSYLCERAMIDE SYNTHASE INHIBITORS

 #8
20190382395
2019-12-19

Tyrosine kinase inhibitors

 #9
20190209550
2019-07-11

Azadecalin derivatives as inhibitors of human immunodeficiency virus replication

 #10
20190105643
2019-04-11

Cinchonium betaine catalysts and methods of using same

 #11
20190015402
2019-01-17

Anti-Viral Compounds

 #12
20180230157
2018-08-16

Pyrrolo[1,2-b]pyridazine derivatives

 #13
20170044155
2017-02-16

Geminal substituted aminobenzisoxazole compounds as agonists of α7-nicotinic acetylcholine receptors

 #14
20160039805
2016-02-11

Salt forms of (S)-quinuclidin-3-yl (2-(2-(4-fluorophenyl)thiazol-4-yl)propan-2-yl)carbamate

 #15
20160024075
2016-01-28

INDOLE AND BENZOFURAN FUSED ISOQUINUCLIDENE DERIVATIVES AND PROCESSES FOR PREPARING THEM

 #16
20150087618
2015-03-26

Anti-viral compounds

 #17
20140371460
2014-12-18

Glucosylceramide synthase inhibitors

 #18
20140357741
2014-12-04

Methods and compositions for preparing and purifying noribogaine

 #19
20140255381
2014-09-11

Glucosylceramide synthase inhibitors

 #20
20140155428
2014-06-05

Compounds

 #21
20140155427
2014-06-05

Compounds

 #22
20140155373
2014-06-05

Inhibitors of PDE4 enzyme and antagonists of muscarinic M3 receptor

 #23
20130095193
2013-04-18

Aminopyrazines as ATR kinase inhibitors

 #24
20130060036
2013-03-07

PROCESS FOR PRODUCTION OF QUINUCLIDINE COMPOUNDS

 #25
20120316126
2012-12-13

Compounds for the Treatment of Hepatitis C

 #26
20120201783
2012-08-09

Compounds for the treatment of hepatitis C

 #27
20120114599
2012-05-10

Opioid and opioid-like compounds and uses thereof

 #28
20120046271
2012-02-23

2,5-methano- and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin

 #29
20120004196
2012-01-05

Anti-viral compounds

 #30
20110256099
2011-10-20

Compounds for the treatment of hepatitis C

 #31
20110207699
2011-08-25

Anti-viral compounds

 #32
20110172174
2011-07-14

Antibacterial agents

 #33
20110166169
2011-07-07

HSP90 inhibitory carbazole derivatives, compositions containing same and use thereof

 #34
20110092415
2011-04-21

Anti-Viral Compounds

 #35
20100324025
2010-12-23

Antibacterial agents

 #36
20100317568
2010-12-16

Anti-viral compounds

 #37
20100249094
2010-09-30

Compounds for the treatment of hepatitis C

 #38
20100145055
2010-06-10

METHOD FOR THE PREPARATION OF SOLIFENACIN

 #39
20100093694
2010-04-15

Compounds for the treatment of hepatitis C

 #40
20100009960
2010-01-14

Pyridone/hydroxypyridine 11-beta hydroxysteroid dehydrogenase type I inhibitors

 #41
20090247506
2009-10-01

Antibacterial agents

 #42
20090169508
2009-07-02

Opioid and opioid-like compounds and uses thereof

 #43
20090163496
2009-06-25

Antibacterial agents

 #44
20080269221
2008-10-30

Antibacterial agents

 #45
20070244197
2007-10-18

Antibacterial agents

 #46
20060154988
2006-07-13

Antibacterial agents

 #47
20060063809
2006-03-23

Tri-substituted heteroaryls and methods of making and using the same